We are live on ! Find out more
SRTS icon

Sensus Healthcare

81 hedge funds and large institutions have $76.9M invested in Sensus Healthcare in 2022 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 17 increasing their positions, 21 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

627% more call options, than puts

Call options by funds: $5.33M | Put options by funds: $733K

357% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 7

97% more capital invested

Capital invested by funds: $39.1M → $76.9M (+$37.8M)

45% more funds holding

Funds holding: 5681 (+25)

6.57% more ownership

Funds ownership: 30.44%37.01% (+6.6%)

19% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 21

Holders
81
Holders Change
+25
Holders Change %
+44.64%
% of All Funds
1.4%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
32
Increased
17
Reduced
21
Closed
7
Calls
$5.33M
Puts
$733K
Net Calls
+$4.6M
Net Calls Change
+$3.31M
Name Holding Trade Value Shares
Change
Change in
Stake
Acadian Asset Management
1
Acadian Asset Management
Massachusetts
$7.46M +$158K +13,234 +2%
Vanguard Group
2
Vanguard Group
Pennsylvania
$7.44M
HIM
3
Hillsdale Investment Management
Ontario, Canada
$6.82M -$1.22M -102,200 -16%
GIPM
4
G2 Investment Partners Management
New York
$5.79M +$5.52M +462,175 New
Morgan Stanley
5
Morgan Stanley
New York
$4.2M +$1.28M +107,311 +47%
EI
6
EAM Investors
California
$4.1M -$20.5K -1,719 -0.5%
PAIM
7
Punch & Associates Investment Management
Minnesota
$3.79M +$1.4M +117,340 +63%
Renaissance Technologies
8
Renaissance Technologies
New York
$3.33M +$628K +52,600 +25%
Dimensional Fund Advisors
9
Dimensional Fund Advisors
Texas
$2.45M
DSCM
10
Divisadero Street Capital Management
Florida
$2.25M +$2.15M +180,000 New
EGI
11
EAM Global Investors
California
$2.2M
Ameriprise
12
Ameriprise
Minnesota
$1.68M -$439K -36,763 -23%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$1.52M -$9.87K -826 -0.7%
IP
14
Invenire Partners
Connecticut
$1.49M +$1.42M +118,867 New
NA
15
Navellier & Associates
Nevada
$1.48M -$30.1K -2,516 -2%
Norges Bank
16
Norges Bank
Norway
$1.29M +$1.23M +102,800 New
Arrowstreet Capital
17
Arrowstreet Capital
Massachusetts
$1.21M +$295K +24,681 +34%
EWM
18
Empirical Wealth Management
Washington
$1.21M
UBS Group
19
UBS Group
Switzerland
$1.05M -$151K -12,649 -13%
Bank of New York Mellon
20
Bank of New York Mellon
New York
$894K +$65.7K +5,501 +8%
DC
21
Diametric Capital
Massachusetts
$826K +$788K +65,937 New
CSS
22
Cubist Systematic Strategies
Connecticut
$787K +$469K +39,273 +167%
Calamos Advisors
23
Calamos Advisors
Illinois
$762K +$726K +60,785 New
BlackRock
24
BlackRock
New York
$753K +$105K +8,774 +17%
Simplex Trading
25
Simplex Trading
Illinois
$623K +$275K +23,015 +86%

SRTS Hedge Fund Activity: Q3 2022 in Review

81 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Sensus Healthcare (SRTS) for Q3 2022, worth a combined $76.9M — up 97% from $39.1M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new SRTS positions and 7 closed out — a net gain of 25 holders — while 17 added to existing stakes and 21 trimmed.

The largest buyer was G2 Investment Partners Management, opening a new position worth an estimated $5.52M. The largest seller was Millennium Management, cutting an estimated $2.17M.

  • 81 institutional investors held Sensus Healthcare (SRTS) as of Q3 2022, up from 56 in Q2 2022.
  • Funds reported $76.9M of Sensus Healthcare stock for Q3 2022, up 97% quarter-over-quarter.
  • 32 funds opened new Sensus Healthcare positions in Q3 2022 and 7 closed out, a net change of +25 holders.
  • The largest Sensus Healthcare buyer in Q3 2022 was G2 Investment Partners Management, an estimated $5.52M added.
  • The largest Sensus Healthcare seller in Q3 2022 was Millennium Management, an estimated $2.17M sold.

Based on aggregated 13F filings for Q3 2022.